VBL Therapeutics (VBLT) Stock: Flying On Data Presentation
VBL Therapeutics (NASDAQ: VBLT) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company presented data with regard to its novel MOSPD2 program in oncology and inflammation, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The data; what we’re seeing from the … Read more